Effect of Stevia on Glycemic and Insulin Responses in Obese Patients—A Randomized, Double-Blind, Placebo-Controlled Crossover Study
Samakkarnthai, P; Payanundana, M; Sathavarodoom, N; Siriwan, C; Boonyavarakul, A
Jun 22, 2018
Diabetes, vol. 67, no. Supplement 1, American Diabetes Association, July 2018. diabetes.diabetesjournals.org, https://doi.org/10.2337/db18-790-P.
Background: Stevia is natural nonnutritive sweeteners (NNS) that is considered to be metabolic inert in contrast with artificial NNS, especially sucralose, which cause glucose intolerant in obese patients. However, acute effect of stevia ingestion on glycemic and insulin responses in obese patients are not clearly established.
Objectives:To assess acute effect of stevia on glycemic and insulin responses in obese patients.
Material and Methods: Obese patients underwent a 75 gram oral glucose tolerance test (OGTT) preceded by consuming pills containing either 200 mg stevia or placebo for 60 minutes before test on two separate occasions, 1 week apart, in a randomized crossover design. Blood samples were obtained for glucose and insulin at 0,30,60,90 and 120 minutes. Area under the curve (AUC) of glucose and insulin responses were calculated. Indices for insulin sensitivity (Matsuda index) and Insulin secretion (Insulinogenic index) were calculated using minimal models of glucose and insulin kinetics.
Results: Twenty obese patients (BMI 28.75±3.68 kg/m2) were recruited to the study. There were no significant differences in AUC of glucose and insulin between stevia and placebo (glucose, 15,285±4,531 vs. 15,101 ±3,955, p=0.89 and insulin 8,507 ±5,858 vs. 7,652 ± 5,020,p=0.62) Insulin sensitivity derived from OGTT using Matsuda index was not significant difference between stevia and placebo (4.74±1.86 vs. 5.84±2.96,p=0.09). Insulin secretion using Insulinogenic index was not significant difference between stevia and placebo (p=0.155).
Conclusions: Stevia does not affect in acute glycemic and insulin responses to OGTT in obese patients. This findings need to be determined in longer duration of ingestion study.
The information on this website has not been evaluated by the Food & Drug Administration or any other medical body. We do not aim to diagnose, treat, cure or prevent any illness or disease. Information is shared for educational purposes only. The content of this blog is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard, or delay in obtaining, medical advice for any medical condition they may have, and should seek the assistance of their health care professionals for any such conditions. You must consult your doctor before acting on any content on this website, especially if you are pregnant, nursing, taking medication, or have a medical condition.
© 2021 by Flexible Fasting • All rights reserved • Created + Maintained by EmDesign